Table 3.
Baseline weighted prevalence (95% CI) of number of ideal CVH metrics by sex from the NHES IV in 2009 and the NHES V in 2014.
| NHES IV | NHES V | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | Male | Female | Total | Number | Male | Female | Total | P -value | |
| Number of ideal CVH metrics | 15,219 | 14,499 | |||||||
| 0–1 | 2789 | 19.5 (16.9, 22.4) | 8.4 (7.2, 9.6) | 13.7 (12.0, 15.6) | 3176 | 26.2 (23.8, 28.9) | 12.1 (10.6, 13.8) | 18.7 (17.1, 20.5) | < 0.001 |
| 2 | 4254 | 27.7 (25.7, 29.8) | 22.4 920.8, 24.1) | 25.0 (23.7, 26.3) | 4284 | 28.7 (26.5, 31.1) | 25.8 (24.0, 27.6) | 27.2 (25.5, 28.9) | |
| 3 | 4167 | 29.9 (27.6, 32.3) | 29.6 (27.9, 31.4) | 29.8 (28.3, 31.2) | 3727 | 25.1 (23.5, 26.8) | 28.3 (26.2, 30.5) | 26.8 (25.5, 28.1) | |
| 4 | 2686 | 16.9 (15.9, 18.0) | 25.2 (23.5, 27.0) | 21.2 (20.4, 22.1) | 2188 | 14.3 (13.0, 15.8) | 21.0 (19.3, 22.7) | 17.9 (16.6, 19.2) | |
| 5–7 | 1323 | 6.0 (5.1, 6.9) | 14.4 (12.7, 16.3) | 10.4 (9.2, 11.6) | 1124 | 5.6 (4.7, 6.7) | 12.9 (11.4, 14.5) | 9.5 (8.6, 10.4) | |
| Overall CVH score | |||||||||
| Inadequate (0–6) | 5714 | 35.7 (33.1, 38.5) | 25.6 (23.6, 27.6) | 30.5 (28.5, 32.5) | 5966 | 42.1 (39.6, 44.6) | 30.8 (28.6, 33.1) | 36.1 (34.2, 38.1) | < 0.001 |
| Average (7–8) | 5161 | 37.3 (35.4, 39.2) | 35.0 (33.1, 37.0) | 36.1 (34.6, 37.6) | 4785 | 33.9 (31.6, 36.3) | 33.6 (32.3, 34.8) | 33.7 (32.4, 35.1) | |
| Optimal (9–14) | 4344 | 27.0(25.3, 28.7) | 39.4 (37.1, 41.8) | 33.4 (31.8, 35.1) | 3748 | 24.0 (21.7, 26.5) | 35.6 (33.3, 37.9) | 30.2 (28.1, 32.3) | |
*P-value for Chi-squared test.